| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685460 | American Journal of Kidney Diseases | 2017 | 8 Pages |
Abstract
This pilot study suggests that intraperitoneal vancomycin with oral moxifloxacin is a safe, well-tolerated, practical, and effective first-line treatment for PD-related peritonitis. Larger adequately powered clinical trials are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Rong MD, Zhikai MD, Zhen MD, Huan BS, Xue MS, David W. MD, Jie MD,